These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1836395)

  • 1. Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist with rheumatoid synovial cells.
    Arend WP; Coll BP
    Cytokine; 1991 Sep; 3(5):407-13. PubMed ID: 1836395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.
    Granowitz EV; Clark BD; Vannier E; Callahan MV; Dinarello CA
    Blood; 1992 May; 79(9):2356-63. PubMed ID: 1533322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
    McColl SR; Paquin R; Ménard C; Beaulieu AD
    J Exp Med; 1992 Aug; 176(2):593-8. PubMed ID: 1386877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells.
    Chin J; Rupp E; Cameron PM; MacNaul KL; Lotke PA; Tocci MJ; Schmidt JA; Bayne EK
    J Clin Invest; 1988 Aug; 82(2):420-6. PubMed ID: 2969918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
    J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody based enzyme-linked and chemiluminescent assays for the human interleukin-1 receptor antagonist. Application to measure hIL-1ra levels in monocyte cultures and synovial fluids.
    Towbin H; Schmitz A; van Oostrum J; Seitz M; Dewald B; Zingel O; Motz J; Vosbeck K; Rordorf C
    J Immunol Methods; 1994 Mar; 170(1):125-35. PubMed ID: 8157985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
    McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
    J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
    Hart PH; Ahern MJ; Smith MD; Finlay-Jones JJ
    Immunology; 1995 Apr; 84(4):536-42. PubMed ID: 7790026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
    Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
    Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1ra ELISA: reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors.
    Malyak M; Joslin FG; Verderber EL; Eisenberg SP; Arend WP
    J Immunol Methods; 1991 Jul; 140(2):281-8. PubMed ID: 1829749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 receptor antagonist production by human keratinocytes.
    Bigler CF; Norris DA; Weston WL; Arend WP
    J Invest Dermatol; 1992 Jan; 98(1):38-44. PubMed ID: 1530822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens, soluble antigens or allogeneic determinants.
    Nicod LP; el Habre F; Dayer JM
    Cytokine; 1992 Jan; 4(1):29-35. PubMed ID: 1535518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis.
    Fujikawa Y; Shingu M; Torisu T; Masumi S
    Ann Rheum Dis; 1995 Apr; 54(4):318-20. PubMed ID: 7763113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis.
    Deleuran BW; Chu CQ; Field M; Brennan FM; Katsikis P; Feldmann M; Maini RN
    Br J Rheumatol; 1992 Dec; 31(12):801-9. PubMed ID: 1458286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of interleukin 1 activity in synovial fluids and in cultured synovial fluid mononuclear cells.
    Roux-Lombard P; Modoux C; Vischer T; Grassi J; Dayer JM
    J Rheumatol; 1992 Apr; 19(4):517-23. PubMed ID: 1593570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased IL-1 receptor antagonist (IL-1ra) production and decreased IL-1 beta/IL-1ra ratio in mononuclear cells from rheumatoid arthritis patients.
    Shingu M; Fujikawa Y; Wada T; Nonaka S; Nobunaga M
    Br J Rheumatol; 1995 Jan; 34(1):24-30. PubMed ID: 7881833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I.
    Svenson M; Hansen MB; Heegaard P; Abell K; Bendtzen K
    Cytokine; 1993 Sep; 5(5):427-35. PubMed ID: 8142597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently.
    Arend WP; Smith MF; Janson RW; Joslin FG
    J Immunol; 1991 Sep; 147(5):1530-6. PubMed ID: 1831827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Potential contribution from synovial fluid neutrophils.
    Malyak M; Swaney RE; Arend WP
    Arthritis Rheum; 1993 Jun; 36(6):781-9. PubMed ID: 8507219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1beta, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides.
    Alstergren P; Benavente C; Kopp S
    J Oral Maxillofac Surg; 2003 Oct; 61(10):1171-8. PubMed ID: 14586853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.